These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5320454)

  • 41. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
    Russell B; Chalfein F; Prasetyorini B; Kenangalem E; Piera K; Suwanarusk R; Brockman A; Prayoga P; Sugiarto P; Cheng Q; Tjitra E; Anstey NM; Price RN
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1040-5. PubMed ID: 18180357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of new antimalarial drugs.
    Powell RD
    Am J Trop Med Hyg; 1972 Sep; 21(5):744-8. PubMed ID: 4561522
    [No Abstract]   [Full Text] [Related]  

  • 44. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevalence of malaria in Aligarh.
    Mehrunnisa A; Wajihullah ; Saifi MA; Khan HM
    J Commun Dis; 2002 Mar; 34(1):70-7. PubMed ID: 12718345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response to treatment in man of multi-drug resistant Plasmodium falciparum from Panama.
    Glew RH; Miller LH; Collins WE; Howard WA; Wyler DJ; Chaves-Carballo E; Neva FA
    Am J Trop Med Hyg; 1974 Jan; 23(1):1-7. PubMed ID: 4204024
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias.
    Chin W; Contacos PG; Coatney GR; Jeter MH; Alpert E
    Am J Trop Med Hyg; 1967 Sep; 16(5):580-4. PubMed ID: 4861322
    [No Abstract]   [Full Text] [Related]  

  • 48. Double-blind study to assess the efficacy of chlorproguanil given alone or in combination with chloroquine for malaria chemoprophylaxis in an area with Plasmodium falciparum resistance to chloroquine, pyrimethamine and cycloguanil.
    Coosemans MH; Barutwanayo M; Onori E; Otoul C; Gryseels B; Wéry M
    Trans R Soc Trop Med Hyg; 1987; 81(1):151-6. PubMed ID: 3328329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antimalarial chemoprophylaxis in the French army: development from 1986 to 2001].
    Baudon D; Michel R; Meynard JB; Keundjian A; Boutin JP
    Med Trop (Mars); 2001; 61(1):51-5. PubMed ID: 11584656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis.
    Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E
    Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evaluation of CI-564 against blood-induced chlorguanide-sensitive and chlorguanide-resistant strains of vivax malaria.
    Chin W; Coatney GR; King HK
    Am J Trop Med Hyg; 1967 Jan; 16(1):13-4. PubMed ID: 5336629
    [No Abstract]   [Full Text] [Related]  

  • 52. In Vitro Analysis of the Interaction between Atovaquone and Proguanil against Liver Stage Malaria Parasites.
    Barata L; Houzé P; Boutbibe K; Zanghi G; Franetich JF; Mazier D; Clain J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4333-5. PubMed ID: 26926628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chloroquine resistance and Plasmodium falciparum in Punjab, Pakistan during 2000-2001.
    Rana MS; Tanveer A
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):288-91. PubMed ID: 15691126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malaria deaths following inappropriate malaria chemoprophylaxis--United States, 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Jul; 50(28):597-9. PubMed ID: 11476528
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DHFR gene point mutation as a predictor of Plasmodium falciparum resistance to cycloguanil in malaria cases from Africa imported to France.
    Durand R; Ramiliarisoa O; Sécardin Y; Eldin de Pécoulas P; Basco LK; Le Bras J
    Trans R Soc Trop Med Hyg; 1997; 91(4):460-1. PubMed ID: 9373655
    [No Abstract]   [Full Text] [Related]  

  • 57. Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat.
    Waheed AA; Ghanchi NK; Rehman KA; Raza A; Mahmood SF; Beg MA
    Malar J; 2015 Apr; 14():146. PubMed ID: 25889875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.
    Arnold MS; Engel JA; Chua MJ; Fisher GM; Skinner-Adams TS; Andrews KT
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4361-3. PubMed ID: 27114276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chloroquine-resistant malaria.
    Wellems TE; Plowe CV
    J Infect Dis; 2001 Sep; 184(6):770-6. PubMed ID: 11517439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
    Fidock DA; Wellems TE
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10931-6. PubMed ID: 9380737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.